CO-DIAGNOSTICS INC's ticker is and the CUSIP is 189763905. A total of 3 filers reported holding CO-DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,380 | -3.4% | 73,000 | +1.1% | 0.00% | – |
| Q2 2023 | $80,142 | -25.6% | 72,200 | -0.8% | 0.00% | – |
| Q1 2023 | $107,744 | -50.2% | 72,800 | -15.3% | 0.00% | -100.0% |
| Q4 2022 | $216,468 | -45.3% | 85,900 | -30.4% | 0.00% | 0.0% |
| Q3 2022 | $396,000 | -39.2% | 123,500 | +6.5% | 0.00% | 0.0% |
| Q2 2022 | $651,000 | -32.4% | 116,000 | -25.6% | 0.00% | 0.0% |
| Q1 2022 | $963,000 | -16.6% | 155,900 | +20.7% | 0.00% | 0.0% |
| Q4 2021 | $1,154,000 | +105.3% | 129,200 | +123.5% | 0.00% | 0.0% |
| Q3 2021 | $562,000 | -28.8% | 57,800 | -39.5% | 0.00% | 0.0% |
| Q2 2021 | $789,000 | -50.9% | 95,600 | -43.3% | 0.00% | -50.0% |
| Q1 2021 | $1,607,000 | -50.8% | 168,500 | -52.1% | 0.00% | -66.7% |
| Q4 2020 | $3,269,000 | +21.6% | 351,500 | +77.6% | 0.01% | -25.0% |
| Q3 2020 | $2,689,000 | -66.0% | 197,900 | -51.5% | 0.01% | -77.8% |
| Q2 2020 | $7,899,000 | +1639.9% | 408,200 | +584.9% | 0.04% | +800.0% |
| Q1 2020 | $454,000 | – | 59,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 57,800 | $562,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 35,800 | $297,000 | 0.00% |